Energy » Fossil Fuels | Changsheng Biotechnology Co. Ltd.

Changsheng Biotechnology Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
Sales/Revenue
199
619
792
1,012
1,544
Cost of Goods Sold (COGS) incl. D&A
139
162
188
225
223
Gross Income
60
458
604
787
1,321
SG&A Expense
35
209
230
311
735
EBIT
22
-
355
465
586
Unusual Expense
-
-
8
1
-
Non Operating Income/Expense
1
2
2
1
1
Interest Expense
-
-
9
3
1
Pretax Income
41
243
346
502
665
Income Tax
5
35
53
73
97
Equity in Affiliates
-
-
-
1
-
Consolidated Net Income
36
208
293
429
568
Net Income
36
208
293
425
566
Net Income After Extraordinaries
36
208
293
425
566
Net Income Available to Common
36
208
293
425
566
EPS (Basic)
0.13
0.20
1.08
0.44
0.58
Basic Shares Outstanding
272
1,026
272
969
969
EPS (Diluted)
0.13
0.20
1.08
0.44
0.58
Diluted Shares Outstanding
272
1,026
272
969
972
EBITDA
31
274
382
496
622
Other Operating Expense
3
3
1
20
10
Non-Operating Interest Income
11
2
2
35
78
Minority Interest Expense
-
-
-
4
1

About Changsheng Biotechnology Co.

View Profile
Address
No. 1615 Yueda Road
Changchun Jilin 130103
China
Employees -
Website -
Updated 07/08/2019
Changsheng Bio-technology Co., Ltd. engages in the manufacture, research and development, and sale of human vaccines. Its products include vaccine for DTC combines, rabies F and V, varicella, influenza, and hepatitis A. The company was founded on August 18, 1992 and is headquartered in Changchun, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.